US Brachytherapy Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Brachytherapy Market 

5.1. COVID-19 Landscape: Brachytherapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. US Brachytherapy Market, By Dosage

8.1. US Brachytherapy Market, by Dosage

8.1.1 High-dose Rate (HDR) Brachytherapy

8.1.1.1. Market Revenue and Forecast

8.1.2. Low-dose Rate (LDR) Brachytherapy

8.1.2.1. Market Revenue and Forecast

Chapter 9. US Brachytherapy Market, By Product

9.1. US Brachytherapy Market, by Product

9.1.1. Seeds

9.1.1.1. Market Revenue and Forecast

9.1.2. Applicators & Afterloaders

9.1.2.1. Market Revenue and Forecast

9.1.3. Electronic Brachytherapy

9.1.3.1. Market Revenue and Forecast

Chapter 10. US Brachytherapy Market, By Application 

10.1. US Brachytherapy Market, by Application

10.1.1. Prostate Cancer

10.1.1.1. Market Revenue and Forecast

10.1.2. Gynecological Cancer

10.1.2.1. Market Revenue and Forecast

10.1.3. Breast Cancer

10.1.3.1. Market Revenue and Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Forecast

Chapter 11. US Brachytherapy Market, Regional Estimates and Trend Forecast

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Dosage

11.1.4.2. Market Revenue and Forecast, by Product

11.1.4.3. Market Revenue and Forecast, by Application

Chapter 12. Company Profiles

12.1. Varian Medical Systems, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Becton

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Dickinson & Company

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Elekta AB

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Isoray Medical, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Eckert & Ziegler BEBIG

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. iCAD, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. CIVCO Medical Solutions

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Theragenics Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms